Skip to content

Study on the Relationship Between the Expression of Mitochondrial Fission Protein 1 (FIS1) and B-cell Lymphoma 2-like Protein 1 (BCL2L1) in the Blood of Sepsis Patients and the Prognosis of Sepsis

Study on the Relationship Between the Expression of Mitochondrial Fission Protein 1 (FIS1) and B-cell Lymphoma 2-like Protein 1 (BCL2L1) in the Blood of Sepsis Patients and the Prognosis of Sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101408
Enrollment
Unknown
Registered
2025-04-24
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sepsis group:None

Sponsors

Wuhan Fourth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with non-sepsis: 1. All patients who do not meet the diagnosis of sepsis; 2. The exclusion criteria are the same as those for patients with sepsis; 3. Sign the informed consent form. Inclusion criteria for patients with sepsis: meet the diagnostic criteria of the 3rd International Consensus on the Definition of Sepsis and Septic Shock (SEPSIS-3.0) published in 2016, namely: 1. Confirmed or suspected infection: Patients must have evidence of confirmed or suspected infection. 2. Increase in SOFA score: Sequential organ failure score (SOFA) increased by >2 points from baseline. 3. Sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years old. 2. Pregnant and lactating women. 3. Those who have received chemotherapy within 6 months before admission. 4. Those who are currently receiving corticosteroids or other immunosuppressants or immunomodulators within the previous 3 months. 5. People with immune system diseases. 6. HIV-positive people 7. Patients with end-stage liver function or renal failure 8. Not a first-time ICU admission

Design outcomes

Primary

MeasureTime frame
Mitochondrial Fission Protein 1;B-cell Lymphoma 2-like Protein 1;

Countries

China

Contacts

Public ContactHaohao Cao

Wuhan Fourth Hospital

hhcao8050@163.com+86 134 2988 8050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026